Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Kristian Gaarn Du Jardin"'
Autor:
Philip Laws, Kristian Gaarn Du Jardin
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 4, Pp 849-856 (2023)
Abstract Background Tildrakizumab is an interleukin‐23p19 inhibitor approved for the treatment of moderate‐to‐severe plaque psoriasis. The new Dermatology Life Quality Index (DLQI)‐Relevant (DLQI‐R) scoring system avoids the bias in the not
Externí odkaz:
https://doaj.org/article/5d38a43e259249cab79fd4c2abff25ff
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Background Five-year tildrakizumab safety data have been reported as exposure-adjusted incidence rates (EAIRs) of patients with events per 100 patient-years (PYs) of exposure. Objectives To present 5-year safety data from reSURFACE 1/2 phase 3 trials
Externí odkaz:
https://doaj.org/article/c4b92278d4af48e2a8cee67af1d1b83c
Autor:
Elke L. M. ter Haar, Juul M. P. A. van den Reek, Kristian Gaarn Du Jardin, Almudena Barbero-Castillo, Elke M. G. J. de Jong, Satish F. K. Lubeek
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
The evidence on treating older patients with psoriasis with modern biologics is scarce. This study compared the efficacy and safety of tildrakizumab among younger and older patients with psoriasis (
Externí odkaz:
https://doaj.org/article/c8c47d9828354437a429231c9fef21e9
Autor:
Jessica A. Waller, Sara Holm Nygaard, Yan Li, Kristian Gaarn du Jardin, Joseph A. Tamm, Aicha Abdourahman, Betina Elfving, Alan L. Pehrson, Connie Sánchez, Rasmus Wernersson
Publikováno v:
BMC Neuroscience, Vol 18, Iss 1, Pp 1-15 (2017)
Abstract Background The identification of biomarkers that predict susceptibility to major depressive disorder and treatment response to antidepressants is a major challenge. Vortioxetine is a novel multimodal antidepressant that possesses pro-cogniti
Externí odkaz:
https://doaj.org/article/6ad74c4aa9b34a46b8e8a08350e7b99c
Autor:
Antonio Costanzo, Mar Llamas‐Velasco, Gabriella Fabbrocini, Aldo Cuccia, Raquel Rivera‐Diaz, Kristian Gaarn Du Jardin, Ismail Kasujee, Lluís Puig, José Manuel Carrascosa
Publikováno v:
Journal of the European Academy of Dermatology and Venereology.
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB161
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB113
Autor:
Gregers Wegener, Betina Elfving, Nico Liebenberg, Manuel Cajina, Connie Sanchez, Kristian Gaarn du Jardin, Heidi Kaastrup Müller
Publikováno v:
Frontiers in Pharmacology
du Jardin, K G, Liebenberg, N, Cajina, M, Müller, H K, Elfving, B, Sanchez, C & Wegener, G 2017, ' S-Ketamine Mediates Its Acute and Sustained Antidepressant-Like Activity through a 5-HT1B Receptor Dependent Mechanism in a Genetic Rat Model of Depression ', Frontiers in Pharmacology, vol. 8, pp. 978 . https://doi.org/10.3389/fphar.2017.00978
Frontiers in Pharmacology, Vol 8 (2018)
du Jardin, K G, Liebenberg, N, Cajina, M, Müller, H K, Elfving, B, Sanchez, C & Wegener, G 2017, ' S-Ketamine Mediates Its Acute and Sustained Antidepressant-Like Activity through a 5-HT1B Receptor Dependent Mechanism in a Genetic Rat Model of Depression ', Frontiers in Pharmacology, vol. 8, pp. 978 . https://doi.org/10.3389/fphar.2017.00978
Frontiers in Pharmacology, Vol 8 (2018)
Rationale: The mechanisms responsible for the unique antidepressant properties of ketamine have only been partly resolved. Recent preclinical reports implicate the neurotransmitter serotonin (5-hydroxytryptamine; 5-HT) in the antidepressant-like resp
Autor:
Yan Li, Connie Sanchez, Betina Elfving, Alan L. Pehrson, Joseph A. Tamm, Aicha Abdourahman, Kristian Gaarn du Jardin, Sara Holm Nygaard, Rasmus Wernersson, Jessica A. Waller
Publikováno v:
BMC Neuroscience
BMC Neuroscience, Vol 18, Iss 1, Pp 1-15 (2017)
Waller, J A, Nygaard, S H, Li, Y, du Jardin, K G, Tamm, J A, Abdourahman, A, Elfving, B, Pehrson, A L, Sánchez, C & Wernersson, R 2017, ' Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents ', B M C Neuroscience, vol. 18, no. 1, pp. 56 . https://doi.org/10.1186/s12868-017-0376-x
Waller, J A, Nygaard, S H, Li, Y, Jardin, K G, Tamm, J A, Abdourahman, A, Elfving, B, Pehrson, A L, Sanchez, C & Wernersson, R 2017, ' Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents ', BMC Neuroscience, vol. 18, no. 1, 56 . https://doi.org/10.1186/s12868-017-0376-x
BMC Neuroscience, Vol 18, Iss 1, Pp 1-15 (2017)
Waller, J A, Nygaard, S H, Li, Y, du Jardin, K G, Tamm, J A, Abdourahman, A, Elfving, B, Pehrson, A L, Sánchez, C & Wernersson, R 2017, ' Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents ', B M C Neuroscience, vol. 18, no. 1, pp. 56 . https://doi.org/10.1186/s12868-017-0376-x
Waller, J A, Nygaard, S H, Li, Y, Jardin, K G, Tamm, J A, Abdourahman, A, Elfving, B, Pehrson, A L, Sanchez, C & Wernersson, R 2017, ' Neuroplasticity pathways and protein-interaction networks are modulated by vortioxetine in rodents ', BMC Neuroscience, vol. 18, no. 1, 56 . https://doi.org/10.1186/s12868-017-0376-x
Background The identification of biomarkers that predict susceptibility to major depressive disorder and treatment response to antidepressants is a major challenge. Vortioxetine is a novel multimodal antidepressant that possesses pro-cognitive proper